Track the Inhibrx Biosciences, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.2bn. The latest transaction was filed on 9 October 2025 (Cession). Among the most active insiders: Kayyem Jon Faiz. The full history is free.
22
Insider Decl.
n/a
Thresholds
€4m
12 ops.
Buy Volume
€9m
1 ops.
Sell Volume
55Σ signal
Buys €4m€9m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Inhibrx Biosciences, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of cancer and other serious diseases. The company is listed on NASDAQ under the ticker INBX.